Sude Kendirli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sude Kendirli has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Miruna F. Ates
Neurology, Maltepe University, School of Medicine, Istanbul, TUR
1 shared publication- Nilgun Cinar
Department of Neurology, Maltepe University, Faculty of Medicine, Istanbul, Türkiye
1 shared publication Sevki Sahin
Neurology, Maltepe University, School of Medicine, Istanbul, TUR
1 shared publication- Sibel Karsidag
Department of Neurology, School of Medicine, Maltepe University, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 19 August 2021
- Published by Springer Nature in Cureus
- Vol. 13 (8)
Demyelinating Disease of the Central Nervous System Concurrent With COVID-19
Neurological diseases related to coronavirus disease-2019 (COVID-19) are increasingly reported. We report here three cases that presented with subtle neurologic findings manifesting within a range of 15 days to four months after their COVID-19 diagnoses. Magnetic resonance imaging showed acute multifocal periventricular and subcortical demyelinating lesions. Some of the lesions showed contrast enhancement and diffusion restriction. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR was found in the cerebrospinal fluid of just one patient. All patients received intravenous methylprednisolone therapy. In this report, we aim to discuss the aspects of possible COVID-19-related demyelination that support a diagnosis of multiple sclerosis (MS) or acute disseminated encephalomyelitis (ADEM).
- 19 August 2021
- Published by Springer Nature in Cureus
- Vol. 13 (8)
Open AccessDemyelinating Disease of the Central Nervous System Concurrent With COVID-19
Neurological diseases related to coronavirus disease-2019 (COVID-19) are increasingly reported. We report here three cases that presented with subtle neurologic findings manifesting within a range of 15 days to four months after their COVID-19 diagnoses. Magnetic resonance imaging showed acute multifocal periventricular and subcortical demyelinating lesions. Some of the lesions showed contrast enhancement and diffusion restriction. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR was found in the cerebrospinal fluid of just one patient. All patients received intravenous methylprednisolone therapy. In this report, we aim to discuss the aspects of possible COVID-19-related demyelination that support a diagnosis of multiple sclerosis (MS) or acute disseminated encephalomyelitis (ADEM).